Biotechnology in Japan
Biotechnology in Japan
SUMMARY
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Japanese biotechnology market had total revenues of $39.1bn in 2019, representing a compound annual growth rate (CAGR) of 3.1% between 2015 and 2019.
- The environment and industrial processing segment was the market's most lucrative in 2019, with total revenues of $15.2bn, equivalent to 38.9% of the market's overall value.
- Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
- What was the size of the Japan biotechnology market by value in 2019?
- What will be the size of the Japan biotechnology market in 2024?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any new product launches in recent years?
7.4. What has been the rationale behind M&A activity in recent years?
7.5. Are there any notable threats to leading players in this market?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Bunge Limited
8.2. Mitsubishi Tanabe Pharma Corporation
8.3. Daiichi Sankyo Co Ltd
8.4. Takeda Pharmaceutical Company Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any new product launches in recent years?
7.4. What has been the rationale behind M&A activity in recent years?
7.5. Are there any notable threats to leading players in this market?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Bunge Limited
8.2. Mitsubishi Tanabe Pharma Corporation
8.3. Daiichi Sankyo Co Ltd
8.4. Takeda Pharmaceutical Company Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Japan biotechnology industry value: $ billion, 2015-19
Table 2: Japan biotechnology industry category segmentation: $ billion, 2019
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2019
Table 4: Japan biotechnology industry value forecast: $ billion, 2019-24
Table 5: Bunge Limited: key facts
Table 6: Bunge Limited: Annual Financial Ratios
Table 7: Bunge Limited: Key Employees
Table 8: Mitsubishi Tanabe Pharma Corporation: key facts
Table 9: Mitsubishi Tanabe Pharma Corporation: Annual Financial Ratios
Table 10: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 11: Daiichi Sankyo Co Ltd: key facts
Table 12: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 13: Daiichi Sankyo Co Ltd: Key Employees
Table 14: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 15: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 16: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 19: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 20: Takeda Pharmaceutical Company Limited: Key Employees
Table 21: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 22: Japan size of population (million), 2015-19
Table 23: Japan gdp (constant 2005 prices, $ billion), 2015-19
Table 24: Japan gdp (current prices, $ billion), 2015-19
Table 25: Japan inflation, 2015-19
Table 26: Japan consumer price index (absolute), 2015-19
Table 27: Japan exchange rate, 2015-19
Table 1: Japan biotechnology industry value: $ billion, 2015-19
Table 2: Japan biotechnology industry category segmentation: $ billion, 2019
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2019
Table 4: Japan biotechnology industry value forecast: $ billion, 2019-24
Table 5: Bunge Limited: key facts
Table 6: Bunge Limited: Annual Financial Ratios
Table 7: Bunge Limited: Key Employees
Table 8: Mitsubishi Tanabe Pharma Corporation: key facts
Table 9: Mitsubishi Tanabe Pharma Corporation: Annual Financial Ratios
Table 10: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 11: Daiichi Sankyo Co Ltd: key facts
Table 12: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 13: Daiichi Sankyo Co Ltd: Key Employees
Table 14: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 15: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 16: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 19: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 20: Takeda Pharmaceutical Company Limited: Key Employees
Table 21: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 22: Japan size of population (million), 2015-19
Table 23: Japan gdp (constant 2005 prices, $ billion), 2015-19
Table 24: Japan gdp (current prices, $ billion), 2015-19
Table 25: Japan inflation, 2015-19
Table 26: Japan consumer price index (absolute), 2015-19
Table 27: Japan exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Japan biotechnology industry value: $ billion, 2015-19
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Japan biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2019
Figure 1: Japan biotechnology industry value: $ billion, 2015-19
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Japan biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2019
